Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | GBA1 | P04062 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.32 |
| ▸ | ABHD16A | O95870 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11030456 | 0.98 | CYP1A2 (0.34) | TP53GAAGBA1CYP1A2ABHD16A | |
| SCHEMBL11859129 | 0.98 | CYP1A2 (0.34) | TP53GAAGBA1CYP1A2ABHD16A | |
| SCHEMBL11855850 | 0.94 | ELANE (0.34) | TP53GAACYP1A2ELANEMEN1 | |
| SCHEMBL2284084 | 0.73 | CYP1A2 (0.31) | CYP1A2ABHD16A | |
| SCHEMBL7887401 | 0.70 | PTGS1 (0.42) | TP53GAAGBA1CYP1A2ALDH1A1 | |
| SCHEMBL7769930 | 0.69 | HDAC6 (0.35) | — | |
| SCHEMBL11861217 | 0.66 | CYP1A2 (0.34) | TP53GAAGBA1CYP1A2GRM2 | |
| SCHEMBL11863305 | 0.66 | CYP1A2 (0.34) | TP53GAAGBA1CYP1A2ABHD16A | |
| SCHEMBL11865901 | 0.66 | CYP1A2 (0.34) | TP53GAAGBA1CYP1A2ABHD16A | |
| SCHEMBL11853103 | 0.66 | CYP1A2 (0.34) | TP53GAAGBA1CYP1A2ABHD16A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080299161-A1 | Solid Biocide Composition and Sealed Biocide Article | SANDERSON WILLIAM D | 2008-12-04 | — | — | US | claimed |
| US-20090232903-A1 | BIOCIDE COMPOSITIONS | SANDERSON WILLIAM D | 2009-09-17 | — | — | US | disclosed |
| US-20080299161-A1 | Solid Biocide Composition and Sealed Biocide Article | SANDERSON WILLIAM D | 2008-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090232903-A1 | BIOCIDE COMPOSITIONS | CAT, BLVRB, BLK | TP53 281/4885GAA 1966/4885GBA1 674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.